Drug therapy for prevention of atrial fibrillation
Authors:
- Olivier ThomasOTOlivier Thomas
- Antoine LeenhardtALAntoine Leenhardt
- 1 January 1996
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 77 (3) , 3A-9A
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Atrial Fibrillation Begets Atrial FibrillationCirculation, 1995
- Spatial and Temporal Inhomogeneity of Adenosine's Effect on Atrial Refractoriness in Humans:Journal of Cardiovascular Electrophysiology, 1994
- Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillationJACC, 1992
- On the mechanism of termination and perpetuation of atrial fibrillationThe American Journal of Cardiology, 1992
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Autonomic Interactions in Cardiac ControlaAnnals of the New York Academy of Sciences, 1990
- Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues.Circulation, 1990
- Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs.Circulation Research, 1988
- Electrogenic sodium extrusion can stop triggered activity in the canine coronary sinus.Circulation Research, 1981
- Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm.Heart, 1975